J2KBIO Co., Ltd.

420570 · KQ · Basic Materials / Specialty Chemicals

8,590.00KRW+180.00 (+2.14%)

Price History

Full chart

Market Stats

Previous Close8,410.00

Open8,470.00

Day Range8,290.00 – 8,640.00

52-Week Range6,710.00 – 12,860.00

Volume12.05K

Market Cap52.92B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.76%

Beta0.30

50-Day Avg9,495.80

200-Day Avg8,520.80

About

J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.

Company Details

SectorBasic Materials
IndustrySpecialty Chemicals
CEOJaeseop Lee
Employees54
Headquarters50-3 Dureungyuri-Ro, Cheongju, South Korea, 28104, Korea
Websitehttps://www.j2kbio.com

Leadership

Jaeseop LeeChief Executive Officer

Financials

Income Statement

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	14.22B	16.03B	28.47B	33.13B	32.97B
Growth (%)	-	+12.75%	+77.60%	+16.36%	-0.49%
Cost of Revenue	8.29B	8.97B	16.97B	20.47B	19.99B
Gross Profit	5.93B	7.06B	11.50B	12.66B	12.98B
Gross Margin	41.70%	44.02%	40.40%	38.21%	39.37%
Operating Expense	4.06B	4.73B	5.90B	9.03B	10.06B
Operating Income	1.87B	2.32B	5.60B	3.63B	2.92B
Operating Margin	13.18%	14.50%	19.67%	10.95%	8.86%
EBITDA	-	3.00B	6.38B	-146.78M	4.59B
EBITDA Margin	-	18.70%	22.42%	-0.44%	13.92%
Net Income	1.62B	2.09B	4.84B	-1.65B	2.67B
Net Income Margin	11.42%	13.01%	17.01%	-4.99%	8.11%
R&D	778.41M	877.86M	1.22B	1.90B	2.43B
R&D as % of Total Revenue	5.47%	5.48%	4.27%	5.74%	7.36%
Interest Expense	202.13M	258.28M	176.48M	95.78M	46.63M
Interest Expense % of Total Revenue	1.42%	1.61%	0.62%	0.29%	0.14%

Balance Sheet

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	16.15B	17.61B	22.02B	35.97B	38.06B
Total Liabilities	7.22B	6.77B	4.20B	4.62B	4.29B
Total Equity	8.87B	10.85B	17.81B	31.34B	33.77B
Cash	4.44B	3.74B	3.92B	6.96B	12.27B

Cash Flow

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	2.00B	1.45B	3.29B	6.94B	2.03B
Investing Cash Flow	-	-1.17B	-594.58M	-3.07B	-
Financing Cash Flow	-	-973.96M	-2.51B	-831.95M	-
Capital Expenditure	851.49M	188.80M	1.63B	7.51B	1.08B
Free Cash Flow	1.15B	1.27B	1.70B	-96.58M	943.96M
Dividends Paid	-	-	240.22M	0	1.15B
FCF to OCF	57.45%	87.55%	51.70%	-1.39%	46.55%
Dividend Paid to FCF	-	-	14.14%	0.00%	121.46%

Earnings

Report Date	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-
EPS Actual	-778.13	453.71	-44.78	50.44	41.50	151.00	143.37	122.21	272.72	455.95
Surprise	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap52.92B

Enterprise Value45.05B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.21

Price / Book1.47

Revenue (TTM)43.90B

Gross Profit (TTM)17.40B

EBITDA8.06B

Profit Margin13.24%

Operating Margin17.26%

Return on Equity16.91%

Return on Assets10.24%

Shares Outstanding5.85M

Shares Float2.21M

Beta0.30

Dividend Yield2.76%

Dividend Rate250.00

Payout Ratio25.14%

Dividends

20251×

250.00Dec 29, 2025

20241×

200.00Dec 27, 2024